The Frequency of Naive and Early-Activated Hapten-Specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse

Laudenbach, M.; Baruffaldi, F.; Vervacke, J. S.; Distefano, M. D.; Titcombe, P. J.; Mueller, D. L.; Tubo, N. J.; Griffith, T. S.; Pravetoni, M.  J. Immunol. 2015, 194, 5926-5936.